Hepatic Artery Infusion Chemotherapy
Showing 1 - 25 of >10,000
Hepatocellular Carcinoma Trial in Guangzhou (Hepatic artery infusion chemo(HAIC), Durvalumab)
Recruiting
- Hepatocellular Carcinoma
- Hepatic artery infusion chemotherapy(HAIC)
- Durvalumab
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
May 18, 2022
Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- TACE-HACI, plus atezolizumab-bevacizumab
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 20, 2023
Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)
Not yet recruiting
- Hepatocellular Carcinoma
- HAIC(FOLFOX)
- +5 more
- (no location specified)
Aug 16, 2022
Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)
Not yet recruiting
- Liver Metastasis Colon Cancer
- TACE and HAIC Combined With Regorafenib
-
Guangzhou, Guangdong, Chinathe first affiliated hospital, Sun-Yat sen university
Oct 2, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)
Recruiting
- Hepatocellular Carcinoma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 4, 2023
Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,
Not yet recruiting
- Hepatocellular Carcinoma
- +3 more
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital, Chongqing Medical University
Jun 9, 2022
Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)
Recruiting
- Colorectal Cancer Metastatic
- Dexamethasone
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 3, 2023
Hepatocellular Carcinoma Trial in Shanghai (Hepatic artery infusion chemo with FOLFOX regimens (oxaliplatin, fluorouracil, and
Recruiting
- Hepatocellular Carcinoma
- Hepatic artery infusion chemotherapy with FOLFOX regimens (oxaliplatin, fluorouracil, and leucovorin)
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Aug 7, 2021
Sequential Regorafenib Plus ICIs After HAIC for Advanced
Recruiting
- Hepatocellular Carcinoma
- Regorafenib combine with ICIs
-
Guangzhou, Guangdong, China
- +1 more
Oct 15, 2022
Hepatocellular Carcinoma Trial in Tianjin (HAIC, Sintilimab, Bevacizumab Biosimilar)
Recruiting
- Hepatocellular Carcinoma
- HAIC
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Jan 16, 2022
Colorectal Cancer, Liver Metastases, Colorectal Adenocarcinoma Trial run by the NCI (device, drug, procedure)
Recruiting
- Colorectal Cancer
- +4 more
- Codman 3000 constant flow pump catheter
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Carcinoma, Carcinoma, Hepatocellular, Liver Tumors Trial in Guangzhou (Hepatic arterial infusion chemo, Folfox Protocol,
Not yet recruiting
- Carcinoma
- +8 more
- Hepatic arterial infusion chemotherapy
- +2 more
-
Guangzhou, Guangdong, ChinaLei Zhang
Sep 22, 2021
Therapeutic Effects and Clinical Prognosis After HAIC for
Recruiting
- Hepatocellular Carcinoma
- Search of factors predicting therapeutic effects and prognosis
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
Jun 7, 2022
Hepatocarcinoma Trial in Shanghai (HAIC+TQB2450+Anlotinib)
Recruiting
- Hepatocarcinoma
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 27, 2022
Hepatocellular Carcinoma Trial (Hepatic Artery Infusion Chemotherapy, Transarterial Chemoembolization, Regorafenib)
Not yet recruiting
- Hepatocellular Carcinoma
- Hepatic Artery Infusion Chemotherapy
- +3 more
- (no location specified)
Feb 7, 2022
Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)
Not yet recruiting
- Cholangiocarcinoma, Intrahepatic
- Recombinant Human Adenovirus Type 5
- HAIC of FOLFOX
-
Beijing, Beijing, ChinaBeijing Tsinghua Chang Gung Hospital
Mar 16, 2022
Locally Advanced Hepatocellular Carcinoma Trial in Hwasun (Vax-NK/HCC)
Recruiting
- Locally Advanced Hepatocellular Carcinoma
- Vax-NK/HCC
-
Hwasun, Jeollanam-do, Korea, Republic ofSeon-Ah Ha
Sep 1, 2021
Unresectable Hepatocellular Carcinoma Trial in Beijing (Camrelizumab, HAIC, TKI)
Recruiting
- Unresectable Hepatocellular Carcinoma
- Camrelizumab
- +2 more
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 22, 2021
Colorectal Cancer, Liver Metastases, Chemo Effect Trial in Oslo (Floxuridine, Liver Transplantation)
Recruiting
- Colorectal Cancer
- +2 more
- Floxuridine
- Liver Transplantation
-
Oslo, NorwayOslo University Hospital
Jul 5, 2021
Bile Duct Tumors, Colorectal Tumors Trial in Lexington (Hepatic artery infusion pump placement using the Synchromed II pump and
Recruiting
- Bile Duct Neoplasms
- Colorectal Neoplasms
- Hepatic artery infusion pump placement using the Synchromed II pump and the Codman tapered arterial catheter.
- +3 more
-
Lexington, KentuckyUniversity of Kentucky
Jun 20, 2021
Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,
Not yet recruiting
- Metastatic Colorectal Carcinoma
- +3 more
- Bevacizumab
- +11 more
- (no location specified)
May 9, 2023
Patient Outcomes After Hepatic Artery Infusion Pump Placement
Recruiting
- Colorectal Liver Metastases
- Colorectal Cancer
-
Rochester, MinnesotaMayo Clinic Rochester
Jul 18, 2022
Recurrent Liver Cancer After Liver Transplantation Trial (Hepatic arterial infusion chemo + Atezolizumab and bevacizumab)
Not yet recruiting
- Recurrent Liver Cancer After Liver Transplantation
- Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab
- (no location specified)
Apr 17, 2023